Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BILASTINE Cause Product use in unapproved indication? 58 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Product use in unapproved indication have been filed in association with BILASTINE. This represents 7.5% of all adverse event reports for BILASTINE.

58
Reports of Product use in unapproved indication with BILASTINE
7.5%
of all BILASTINE reports
3
Deaths
9
Hospitalizations

How Dangerous Is Product use in unapproved indication From BILASTINE?

Of the 58 reports, 3 (5.2%) resulted in death, 9 (15.5%) required hospitalization, and 1 (1.7%) were considered life-threatening.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BILASTINE. However, 58 reports have been filed with the FAERS database.

What Other Side Effects Does BILASTINE Cause?

Urticaria (132) Drug ineffective (127) Pruritus (103) Dyspnoea (93) Malaise (76) Headache (75) Arthralgia (74) Off label use (72) Fatigue (68) Cough (62)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which BILASTINE Alternatives Have Lower Product use in unapproved indication Risk?

BILASTINE vs BIMATOPROST BILASTINE vs BIMATOPROST\TIMOLOL BILASTINE vs BIMEKIZUMAB BILASTINE vs BIMEKIZUMAB-BKZX BILASTINE vs BINIMETINIB

Related Pages

BILASTINE Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication BILASTINE Demographics